Skip to main content
SpringerLink
Log in

Rosuvastatin best bet in fight against CV disease

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosuvastatin best bet in fight against CV disease. Pharmacoecon. Outcomes News 441, 3–4 (2003). https://doi.org/10.1007/BF03277117

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03277117

Keywords

Search

Navigation